Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiora Pharmaceuticals (KPRX) Non-Current Debt (2020 - 2021)

Kiora Pharmaceuticals' Non-Current Debt history spans 2 years, with the latest figure at $278190.0 for Q1 2021.

  • For Q1 2021, Non-Current Debt changed N/A year-over-year to $278190.0; the TTM value through Mar 2021 reached $278190.0, changed N/A, while the annual FY2020 figure was $278190.0, N/A changed from the prior year.
  • Non-Current Debt reached $278190.0 in Q1 2021 per KPRX's latest filing, roughly flat from $278190.0 in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $278190.0 in Q2 2020 to a low of $278190.0 in Q2 2020.